A study of primary care patients in 5 European countries found the mean antibiotic course duration for common respiratory ...

Pope Francis was in critical condition Monday after suffering double pneumonia, but he was battling bronchitis before that.

An obvious advantage of inhaled formulations is delivering respiratory medications ... which are driving research into inhaled treatments for systemic diseases. The interest in inhalation delivery ...

Of children aged 5 to 10 years, about 40% had abnormal lung function post-treatment, rising to 65% in older children.

In 2023, the incidence rate (new cases) of leprosy in Malaysia was seven per million population, an increase from five in million in the preceding year.

Precigen on Tuesday said a green light would make PRGN-2012 the only FDA-approved therapeutic for the treatment of adults with the disorder, which is a lifelong neoplastic disease of the upper and ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

Pope Francis extends hospital stay for multi-infection respiratory illness Vatican updates on Pope Francis health as hospital ...

The pope, 88, was diagnosed with a polymicrobial infection after he was hospitalized in Rome on Friday for bronchitis.

Non-communicable diseases (NCDs) such as cardiovascular diseases, cancer, diabetes, and respiratory illnesses pose a ...

UConn researchers have identified a small molecule that disrupts PRRSV, a virus costing the swine industry billions annually.

PRGN-2012—which Precigen has begun to call by its generic name of zopapogene imadenovec—is a gene therapy designed to elicit immune responses directed against cells infected with human papillomavirus ...